-
|
Reuters –
7:16 AM ET 05/23/2022
- An influential U.S. panel has added screening for chronic kidney disease to its list of preventive services under active consideration, the group's chair told Reuters, a move that could help identify patients eligible for new drugs that treat the disease earlier.
|
-
|
Reuters –
7:00 AM ET 05/23/2022
An influential U.S. panel has added screening for chronic kidney disease to its list of preventive services under active consideration, the group's chair told Reuters, a move that could help identify patients eligible for new drugs that treat the disease earlier.
|
-
|
Benzinga –
1:00 PM ET 05/20/2022
Microdose and appears here with permission. A growing body of research into the therapeutic use of psychedelics, including -- MDMA, psilocybin, LSD, ketamine, and DMT, are delivering promising results to treat a wide range of conditions such as post-traumatic stress disorder, depression, end-of-life anxiety, eating disorders, stroke, and chronic pain.
|
-
|
Benzinga –
10:19 AM ET 05/20/2022
ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug
|
-
|
Reuters –
4:03 PM ET 05/19/2022
- The following is a summary of some recent studies on COVID-19. Post-infection vaccination may reduce long COVID. Vaccination after infection with SARS-CoV-2 may contribute to a reduction in the burden of long COVID symptoms, a new study suggests.
|
-
|
Reuters –
3:59 PM ET 05/19/2022
The following is a summary of some recent studies on COVID-19. Post-infection vaccination may reduce long COVID. Vaccination after infection with SARS-CoV-2 may contribute to a reduction in the burden of long COVID symptoms, a new study suggests.
|
-
|
Benzinga –
12:02 PM ET 05/19/2022
Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson. And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know. So how do we know what this whale just did?
|
-
|
Reuters –
9:50 AM ET 05/19/2022
India has supplied COVID-19 vaccines to Cambodia and Thailand under an initiative of the Quad group of countries, New Delhi said on Thursday, though not the Johnson & Johnson (JNJ) shot as originally planned.
|
-
|
Reuters –
8:50 AM ET 05/19/2022
India has supplied COVID-19 vaccines to Cambodia and Thailand under an initiative of the Quad group of countries that also includes the United States, Japan and Australia, New Delhi said on Thursday. The leaders of the Quad countries could discuss the vaccine supply plan when they meet in Japan next week, Indian foreign ministry spokesperson Arindam Bagchi told a news conference.
|
-
|
Reuters –
8:07 AM ET 05/19/2022
The World Health Organization on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics (CASBF). The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
|
-
|
Benzinga –
6:43 PM ET 05/18/2022
Is the United States heading toward a recession? This has been the looming question on the minds of Americans since inflation topped at 8.5% in March, matched with other indicators such as rising interest rates and the bond market's inverted yield curve. Top economists are split on the inevitability of a recession.
|
-
|
Benzinga –
1:14 PM ET 05/18/2022
In the early days of the psychedelics industry, financial reports mean very little. According to Pharmaceutical Technology, Spravato has struggled to gain market traction since its high price tag and abuse potential often outweigh the significantly added efficacy.
|
-
|
Reuters –
3:00 AM ET 05/18/2022
* Demand for COVID shots drops in Africa as supply rises. * Countries turn to mobile campaigns to boost uptake. * Africa, average age 20, has fared better in pandemic. * Experts warn new variants could emerge on continent. By Edward McAllister and Cooper Inveen. It's noisy inside the Mamprobi clinic in Accra as kids clamber over their mothers while they wait to get their measles vaccines.
|
-
|
Benzinga –
11:15 AM ET 05/17/2022
Analysts have provided the following ratings for Johnson & Johnson within the last quarter: According to 8 analyst offering 12-month price targets in the last 3 months, Johnson & Johnson has an average price target of $193.5 with a high of $210.00 and a low of $173.00. Below is a summary of how these 8 analysts rated Johnson & Johnson over the past 3 months.
|
-
|
Reuters –
8:12 AM ET 05/13/2022
Here's what you need to know about the pandemic right now: North Korea reports first COVID death as fever spreads 'explosively' At least one person confirmed to have COVID has died in North Korea and hundreds of thousands have shown fever symptoms, state media said on Friday, offering hints at the potentially dire scale of the country's first confirmed outbreak of the pandemic.
|
-
|
PR Newswire –
4:30 PM ET 05/12/2022
NEW BRUNSWICK, N.J., May 12, 2022 Johnson & Johnson (JNJ) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16th.
|
-
|
Benzinga –
3:36 PM ET 05/12/2022
Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock
|
-
|
Reuters –
8:12 AM ET 05/12/2022
* South African leader addresses global COVID summit. * Aspen's COVID vaccine capacity at risk. * WHO says lessons will be learnt from Aspen's plight. By Alexander Winning. International agencies and charitable foundations providing COVID-19 vaccines for Africa should order African-made vaccines, South African President Cyril Ramaphosa told a global COVID-19 summit on Thursday.
|
-
|
Reuters –
6:47 AM ET 05/12/2022
A senior World Health Organization official said on Thursday it was "unfortunate" that South African firm Aspen's COVID-19 production facility was at risk of closure for lack of orders but lessons would be learnt.
|
-
|
Benzinga –
4:06 PM ET 05/11/2022
Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco
|
Page:
|
Today's and Upcoming Events
-
JNJ to announce Q2 earnings (Confirmed)
-
JNJ ex-Dividend for $1.13 on 05/23/2022
- Announce Date: 04/19/2022
- Record Date: 05/24/2022
- Pay Date: 06/07/2022
Past Events (last 90 days)
-
JNJ announced Q1 earnings.
Data provided by Thomson Reuters © 2022
|